Database
User
| Compound | Dose | Time | Species | Model | Method | Action | Result | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|---|
| Mdivi-1 | inhibitor | Positive | 296 | ||||||
| Mdivi-1 | Positive | 248 | |||||||
| Urolithin A | enhance | Positive | 248 | ||||||
| Ozone | 1 μg O 3/mL | HeLa cells | Positive | 247 | |||||
| Ozone | 10 μg O 3/mL | HeLa cells | Positive | 247 | |||||
| Nicotine | 10 mM | Human | Human embryonal carcinoma cells (NT2/D1) | Positive | 247 | ||||
| Cisplatin | 3 mg/kg bodyweight | twice a week for 2 weeks | Mouse | Mouse tibial nerves and dorsal root ganglia (L1–L4) | Positive | 247 | |||
| Doxorubicin | 7.2 μM DXR for 24 hrs | Human | fibroblasts | Positive | 247 | ||||
| MDMA | 20 μM MDMA mixture for 24 hrs | Mouse primary hippocampal neurons | Positive | 247 | |||||
| Metamfetamine | 0.5, 1, 2 mM Meth for 24 hrs | Human neuroblastoma SH- SY5Y | Positive | 247 | |||||
| Perfluorooctanoic acid | In utero exposure (GD 1–17) to 1 mg/kg bodyweight dam | Post-natal day 91 mouse livers | Positive | 247 | |||||
| Cadmium | In vitro: 12uM CdCl2 In vivo: 2mg/kg CdCl2 | Rat hepatocytes | Positive | 247 | |||||
| Manganese | Infusion of 1 μM MnCl2 | Rat glia | Positive | 247 | |||||
| Methylmercury | 20 μM | Human HepG2 cells | Positive | 247 | |||||
| Chlorpyrifos | 30 μM | Human stem cell-derived neural progenitor cells | Positive | 247 | |||||
| 2,4-dinitrophenol | 50 μM DNP at 3 hours post fertilization (hpf) | Danio rerio | Positive | 247 | |||||
| CCCP | 20 μM CCCP for 1 to 3 hours | HeLa cells | Positive | 247 | |||||
| FCCP | 10 μM FCCP for 48 to 72 hours | HeLa cells | Positive | 247 | |||||
| Ultraviolet B | 100 mJ/cm2 | human | Normal epidermal keratinocytes | Positive | 247 | ||||
| Ultraviolet C | 60 mJ/cm2 | Mouse | embryonic fibroblasts | Positive | 247 | ||||
| XCT790 | inhibit | Positive | 308 | ||||||
| Rosiglitazone | 1, 2, 4, 7, 24, and 48 hrs | Murine | differentiated 3T3-L1 and C3H/10T1/2 adipocytes | increase | Positive | 179 | |||
| Wortmannin | 100 nM | SH-SY5Y neuroblastoma cells | Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye. | Positive | 252 | ||||
| hydroxychloroquine | 30 μM | SH-SY5Y neuroblastoma cells | Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye. | Positive | 252 | ||||
| 3-methyladenine | 10 mM | SH-SY5Y neuroblastoma cells | Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye. | Positive | 252 | ||||
| Bafilomycin A1 | 50 nM | SH-SY5Y neuroblastoma cells | Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye. | Positive | 252 | ||||
| CCCP | 10 μM or 25 μM | mouse embryonic fibroblasts (MEFs) and SH-SY5Y cells | Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye. | Positive | 252 | ||||
| earle’s balanced salt solution | Positive | 252 | |||||||
| rapamycin | mouse | embryonic retinas | Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye | Positive | 252 | ||||
| Cyclosporin A | 5 μM | mouse embryonic fibroblasts (MEFs) and SH-SY5Y cells | Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye | block | Positive | 252 | |||
| Nicotinamide | 5 mM | 6h | SH-SY5Y cells | Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye. | induce | Positive | 252 | ||
| fisetin | 10 μM | 6h | SH-SY5Y cells | Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye. | induce | Positive | 252 | ||
| Xanthohumol | 30μM | 24hr | MCF7 cells | using the MAP1LC3II/I ratio to monitor the autophagic flux; quantifiedPMPCB staining | block | Positive | 283 | ||
| sertraline | decrease | Positive | 307 | ||||||
| Fluoxetine | decrease | Positive | 307 | ||||||
| quercetin | HepG | Positive | 263 | ||||||
| quercetin | brain | Positive | 265 | ||||||
| colchicine | Positive | 185 | |||||||
| Teriflunomide | induce | Positive | 295 | ||||||
| Leflunomide | 50 μM | 48 hr | HeLa cells, C2C12 muscle cells, MEF cells | Mfn2 and Mfn1 mRNA levels; MFN2, MFN1, and porin protein levels; images of mitochondrial morphology ; | induce | Positive | 295 | ||
| Chlorpyrifos | 30 μM | Human | Human induced pluripotent stem cells (iPSCs) | increase | Positive | 242 | |||
| docetaxel | Positive | 185 | |||||||
| BGP-15 | 50 μM | 4hr | WRL-68 cells | Polyethylene glycol (PEG) fusion assay; OPA1 GTPase assay and OPA1-OPA1 interactions | induce | Positive | 297 | ||
| piceatannol | 48hr | Mfn1−/− MEFs stably expressing an Mfn1 promoter reporter construct | Relative luciferase activity was determined in Mfn1−/− MEFs carrying the Mfn1 promoter reporter | Positive | 276 | ||||